Enzymatica AB:Kallelse till årsstämma 2019 i Enzymatica AB (publ)
April 05, 2019 02:30 ET
|
Enzymatica AB
PressmeddelandeLund den 5 april, 2019 Kallelse till årsstämma 2019 i Enzymatica AB (publ) Aktieägarna i...
Enzymatica AB:Notice of annual general meeting 2019 in Enzymatica AB (publ)
April 05, 2019 02:30 ET
|
Enzymatica AB
Press release 5 April, 2019 Notice of annual general meeting 2019 in Enzymatica AB (publ) The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the “Company”) are hereby...
Enzymatica AB: Enzymatica publicerar årsredovisningen för 2018
April 01, 2019 02:30 ET
|
Enzymatica AB
Pressmeddelande 1 april, 2019 Enzymatica publicerar årsredovisningen för 2018Enzymatica meddelar idag att årsredovisningen för 2018 finns tillgänglig på bolagets hemsida www.enzymatica.se...
Enzymatica AB: - Publication of the annual report 2018
April 01, 2019 02:30 ET
|
Enzymatica AB
Press release 1 April, 2019 Enzymatica - publication of the annual report 2018 Enzymatica announces today that the annual report 2018 is available on the company's web site...
Enzymatica AB: Stark försäljning under fjärde kvartalet, men lägre försäljning för helåret 2018 orsakat av restriktioner i Tyskland
February 19, 2019 02:00 ET
|
Enzymatica AB
Delårsrapport för Enzymatica AB (publ) ...
Enzymatica AB: Strong sales in the fourth quarter, but lower sales for full-year 2018 driven by restrictions in Germany
February 19, 2019 02:00 ET
|
Enzymatica AB
Interim report for Enzymatica AB (publ) ...
Enzymatica AB: Första patienterna inkluderade i stor placebokontrollerad multicenterstudie med ColdZyme
January 30, 2019 02:30 ET
|
Enzymatica AB
Pressmeddelande 30 januari, 2019 Första patienterna inkluderade i stor placebokontrollerad multicenterstudie med ColdZyme Enzymatica har initierat en prospektiv, dubbelblind, placebokontrollerad...
Enzymatica AB: First patients included in large placebo-controlled multicentre study on ColdZyme
January 30, 2019 02:30 ET
|
Enzymatica AB
Press release 30 January 2019 First patients included in large placebo-controlled multicentre study on ColdZyme Enzymatica has initiated a prospective double-blind, placebo-controlled multicentre...
Enzymatica AB: Resultat från den tyska multicenterstudien stärker och breddar ColdZymes produktpåståenden
January 25, 2019 02:30 ET
|
Enzymatica AB
Pressmeddelande 25 januari, 2019 Resultat från den tyska multicenterstudien stärker och breddar ColdZymes produktpåståenden Vid de isländska läkardagarna i Reykjavik presenterade Enzymatica den...
Enzymatica AB: Results from German multicentre study strengthen and broaden ColdZyme's product claims
January 25, 2019 02:30 ET
|
Enzymatica AB
Press release 25 January 2019 Results from German multicentre study strengthen and broaden ColdZyme's product claims At the Icelandic Medical Association conference in Reykjavik on 24 January...